Related Experiment Video
Updated: Feb 3, 2026

Microfluidic Device for the Separation of Non-Metastatic MCF-7 and Non-Tumor MCF-10A Breast Cancer Cells Using AC Dielectrophoresis
Published on: August 11, 2022
MicroRNA-10a promotes granulosa cells tumor development via PTEN-AKT/Wnt regulatory axis
Jiajie Tu1,2,3, Hoi-Hung Cheung1,2, Gang Lu1,2,4
1School of Biomedical Sciences, The Chinese University of Hong Kong, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong SAR, China.
Abstract:
We have previously reported that microRNA-10 family could disturb normal development of granulosa cells (GC) during follicle formation. In the current study, the effect of miR-10a on granulosa cell tumor (GCT), a subtype of ovarian cancer, was examined. Strong miR-10a signal was detected in tissues from malignant GCT patients. Forced expression of miR-10a significantly promoted cell proliferation, migration, invasion, ovarian hormone production, and repressed anticancer drug-induced apoptosis in vitro. The oncogenic role of miR-10a was further validated in an orthotopic GCT model in vivo. In addition, by using CRISPR-Cas9 system, the aggressive phenotype was repressed in miR-10a knockout cancer GC. By using a heterotopic mice model, the oncogenic role of miR-10a was confirmed in vivo. RNA-seq, FISH, western blot, luciferase reporter assay were used to identified PTEN, a well-known anti-GCT gene, as direct functional target of miR-10a in cancer GC; Akt and Wnt were also found as two associated oncogenic pathways of miR-10a in cancer GC. Taken together, our results demonstrate that the miR-10a could promote GCT development via synergistically regulating PTEN, Akt, and Wnt pathways.
Insights
MicroRNA-10a (miR-10a) promotes ovarian cancer growth by targeting PTEN and activating Akt/Wnt pathways. Inhibiting miR-10a suppressed tumor progression in preclinical models, highlighting its potential as a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- MicroRNA-10 family members can disrupt granulosa cell (GC) development.
- Granulosa cell tumors (GCTs) are a significant subtype of ovarian cancer.
Purpose of the Study:
- To investigate the role of miR-10a in the development and progression of granulosa cell tumors (GCTs).
- To identify the molecular mechanisms underlying miR-10a's function in GCTs.
Main Methods:
- Analysis of miR-10a expression in GCT tissues.
- In vitro studies involving forced miR-10a expression and miR-10a knockout in GC cells.
- In vivo validation using orthotopic and heterotopic GCT mouse models.
- RNA-sequencing, FISH, Western blot, and luciferase reporter assays to identify targets and pathways.
Main Results:
- Elevated miR-10a levels were observed in malignant GCT tissues.
- Forced miR-10a expression enhanced GCT cell proliferation, migration, invasion, hormone production, and chemoresistance.
- miR-10a knockout using CRISPR-Cas9 repressed aggressive GCT phenotypes.
- PTEN was identified as a direct target of miR-10a, with Akt and Wnt pathways being associated oncogenic pathways.
Conclusions:
- miR-10a acts as an oncomiR in GCT development.
- miR-10a promotes GCT progression by targeting PTEN and activating Akt and Wnt signaling pathways.
- Targeting miR-10a represents a potential therapeutic strategy for ovarian cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Cis-regulatory Sequences
The Eukaryotic Promoter Region
Hypothalamic-Pituitary Axis
Canonical Wnt Signaling Pathway

